Loading…

Effect of Nd:YAG laser-assisted non-surgical periodontal therapy on clinical periodontal and serum biomarkers in patients with and without coronary artery disease: A short-term pilot study

Background/Objective We hypothesized that nonsurgical‐periodontal‐therapy (NSPT) with adjunct Nd:YAG laser therapy is more effective in reducing periodontal inflammatory parameters (plaque index [PI], bleeding‐on‐probing [BOP], and probing‐pocket‐depth [PPD]) and serum interleukin‐1beta (IL‐1β) and...

Full description

Saved in:
Bibliographic Details
Published in:Lasers in surgery and medicine 2016-12, Vol.48 (10), p.929-935
Main Authors: Javed, Fawad, Kellesarian, Sergio V., Al-Kheraif, Abdulaziz A., Ranna, Vinisha, Qadri, Talat, Yunker, Michael, Malmstrom, Hans, Romanos, Georgios E.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background/Objective We hypothesized that nonsurgical‐periodontal‐therapy (NSPT) with adjunct Nd:YAG laser therapy is more effective in reducing periodontal inflammatory parameters (plaque index [PI], bleeding‐on‐probing [BOP], and probing‐pocket‐depth [PPD]) and serum interleukin‐1beta (IL‐1β) and matrix metalloproteinase‐9 (MMP‐9) levels in patients with and without coronary artery disease (CAD) than NSPT alone. The aim of this short‐term pilot study was to assess the effect of NSPT + Nd:YAG laser therapy on periodontal parameters and serum IL‐1β and MMP‐9 levels in patients with and without CAD. Study Design A prospective randomized clinical study was conducted on 87 patients who were divided into two groups: Group‐1: 44 patients with CAD and periodontal disease (PD) and Group‐2: 43 patients with PD alone. Treatment‐wise, these individuals were randomly divided into two subgroups: (i) NSPT alone and (ii) NSPT + Nd:YAG laser therapy. Demographic information was collected using a self‐completed questionnaire. Periodontal parameters (PI, BOP, and PPD) and serum IL‐1β and MMP‐9 levels were measured at baseline and after 3 months of treatment. P‐values
ISSN:0196-8092
1096-9101
1096-9101
DOI:10.1002/lsm.22483